Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180525 | SCV000232987 | uncertain significance | not provided | 2015-04-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002478600 | SCV002792519 | uncertain significance | Maple syrup urine disease | 2021-09-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002478600 | SCV003449978 | uncertain significance | Maple syrup urine disease | 2020-12-01 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with phenylalanine at codon 426 of the BCKDHA protein (p.Ser426Phe). The serine residue is moderately conserved and there is a large physicochemical difference between serine and phenylalanine. This variant is present in population databases (rs557058340, ExAC 0.02%). This variant has not been reported in the literature in individuals with BCKDHA-related conditions. ClinVar contains an entry for this variant (Variation ID: 199035). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |